Safety and Tolerability of HTI-1066 in Subjects With Advanced Solid Tumors

Recruiting

Phase 1

Safety and Tolerability of HTI-1066 in Subjects With Advanced Solid TumorsSafety and Tolerability of HTI-1066 in Subjects With Advanced Solid Tumors

Sponsor:

Jiangsu HengRui Medicine Co., Ltd.

Code:

NCT03398720

Conditions

Solid Tumor, Adult

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

HTI-1066 dose level 1

HTI-1066 dose level 2

HTI-1066 dose level 3

HTI-1066 dose level 4

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information